Xtant Medical Holdings, Inc. (XTNT) Stock Analysis
A live, multi-source view of Xtant Medical Holdings, Inc. (XTNT): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
Sector: Healthcare · Industry: Medical Devices · United States · 151 employees · xtantmedical.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Xtant Medical Holdings, Inc. (XTNT) had a market capitalization of $52.6M (forward -12.5) and a beta of -0.15; the shares traded in a 52-week range of $0.27 – $0.95 (-37.7% over the year).
- Market cap
- $52.6M
- Enterprise value
- $68.7M
- Forward P/E
- -12.5
- PEG ratio
- 1.74
- Price / book
- 1.32
- EPS (trailing)
- $-0.08
- EPS (forward)
- $-0.03
- Payout ratio
- 0.0%
- 52-week range
- $0.27 – $0.95
- 52-week change
- -37.7%
- Beta
- -0.15
- Average volume
- 1.7M
- Shares outstanding
- 140.3M
- Short % of float
- 0.18%
- Profit margin
- -10.2%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Xtant Medical Holdings, Inc. (XTNT) last closed at $0.34 (the last completed close before that scan).
Technicals at the scan: RSI 42 (neutral territory), price -2.9% versus its 20-day average, 20-day versus 50-day average spread -12.5%, MACD histogram 0.01.
Sentiment inputs: StockTwits 100% bullish.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for XTNT in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
XTNT has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Xtant Medical Holdings, Inc. (XTNT) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell XTNT.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.